Exact Mass: 252.0773

Exact Mass Matches: 252.0773

Found 206 metabolites which its exact mass value is equals to given mass value 252.0773, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Deoxyinosine

9-(2-Deoxy-beta-delta-erythro-pentofuranosyl)-1,9-dihydro-6H-purin-6-one

C10H12N4O4 (252.0859)


Deoxyinosine is a nucleoside that is formed when hypoxanthine is attached to a deoxyribose ring (also known as a ribofuranose) via a beta-N9-glycosidic bond. Deoxyinosine is found in DNA while inosine is found in RNA. Inosine is a nucleic acid important for RNA editing. Adenosine deaminase (ADA) catalyzes the conversion of adenosine and deoxyadenosine to inosine and deoxyinosine, respectively. ADA-deficient individuals suffer from severe combined immunodeficiency (SCID) and are unable to produce significant numbers of mature T or B lymphocytes. This occurs as a consequence of the accumulation of ADA substrates or their metabolites. Inosine is also an intermediate in a chain of purine nucleotides reactions required for muscle movements. Moreover, deoxyinosine is found to be associated with purine nucleoside phosphorylase (PNP) deficiency, which is an inborn error of metabolism. Isolated from Phaseolus vulgaris (kidney bean). 2-Deoxyinosine is found in pulses, yellow wax bean, and green bean. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS 2’-deoxyadenosine inhibits the growth of human colon-carcinoma cell lines and is found to be associated with purine nucleoside phosphorylase (PNP) deficiency. 2’-deoxyadenosine inhibits the growth of human colon-carcinoma cell lines and is found to be associated with purine nucleoside phosphorylase (PNP) deficiency.

   

Nebularine

2-(hydroxymethyl)-5-(9H-purin-9-yl)oxolane-3,4-diol

C10H12N4O4 (252.0859)


Nebularine, also known as purine riboside is found in mushrooms. Nebularine can be isolated from the mushroom Clitocybe nebularis (clouded agaric). Nebularine is a nucleoside analog that is used in a variety of enzyme studies. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000970 - Antineoplastic Agents KEIO_ID P081; [MS2] KO009216 KEIO_ID P081

   

7-methoxyisoflavone

7-methoxyisoflavone

C16H12O3 (252.0786)


A methoxyisoflavone that is isoflavone substituted by a methoxy group at position 7. relative retention time with respect to 9-anthracene Carboxylic Acid is 1.174 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.177 7-Methoxyisoflavone is an isoflavone derivative and also an activator of adenosine monophosphate-activated protein kinase (AMPK).

   

4-O-Methylisoflavone

4-O-Methylisoflavone

C16H12O3 (252.0786)


A methoxyisoflavone that is isoflavone substituted by a methoxy group at position 4.

   

5-Hydroxy-N-formylkynurenine

2-amino-4-(2-formamido-5-hydroxyphenyl)-4-oxobutanoic acid

C11H12N2O5 (252.0746)


5-Hydroxy-N-formylkynurenine is an intermediate in tryptophan metabolism. 5-Hydroxy-N-formylkynurenine is converted from 5-Hydroxy-L-tryptophan via the enzyme, indoleamine 2,3-dioxygenase [EC:1.13.11.52]. [HMDB] 5-Hydroxy-N-formylkynurenine is an intermediate in tryptophan metabolism. 5-Hydroxy-N-formylkynurenine is converted from 5-Hydroxy-L-tryptophan via the enzyme, indoleamine 2,3-dioxygenase [EC:1.13.11.52].

   

UNII-CT7Y6SZA5M

1-[2-(4-Hydroxyphenyl)-1-benzofuran-3-yl]ethanone

C16H12O3 (252.0786)


   

3-Methoxyflavone

3-Methoxyflavone

C16H12O3 (252.0786)


The parent member of the class of 3-methoxyflavones that is flavone which carries a methoxy group at the 3-position.

   

5-Deoxyinosine

5-Deoxyinosine

C10H12N4O4 (252.0859)


A 5-deoxyribonucleoside in which hypoxanthine is attached to 5-deoxyribofuranose via a beta-N(9)-glycosidic bond.

   

Purine nucleoside

Purine nucleoside

C10H12N4O4 (252.0859)


   

7-Hydroxy-2-methylisoflavone

7-Hydroxy-2-methyl-3-phenyl-4H-1-benzopyran-4-one, 9ci

C16H12O3 (252.0786)


7-Hydroxy-2-methylisoflavone is found in herbs and spices. 7-Hydroxy-2-methylisoflavone is isolated from roots of Glycyrrhiza glabra (licorice). Isolated from roots of Glycyrrhiza glabra (licorice). 7-Hydroxy-2-methylisoflavone is found in tea and herbs and spices.

   

Anisindione

2-(4-methoxyphenyl)-2,3-dihydro-1H-indene-1,3-dione

C16H12O3 (252.0786)


Anisindione is a synthetic anticoagulant and an indanedione derivative. It prevents the formation of active procoagulation factors II, VII, IX, and X, as well as the anticoagulant proteins C and S, in the liver by inhibiting the vitamin K-mediated gamma-carboxylation of precursor proteins. C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent

   

N5-(3,4-Dioxo-1,5-cyclohexadien-1-yl)-L-glutamine

2-Amino-4-[(3,4-dioxocyclohexa-1,5-dien-1-yl)-C-hydroxycarbonimidoyl]butanoate

C11H12N2O5 (252.0746)


N5-(3,4-Dioxo-1,5-cyclohexadien-1-yl)-L-glutamine is found in mushrooms. N5-(3,4-Dioxo-1,5-cyclohexadien-1-yl)-L-glutamine is isolated from the mushroom Agaricus bisporus (button mushroom Isolated from the mushroom Agaricus bisporus (button mushroom). N5-(3,4-Dioxo-1,5-cyclohexadien-1-yl)-L-glutamine is found in mushrooms.

   

4-Hydroxyvalerylcarnitine

({3-carboxy-2-[(4-hydroxypentanoyl)oxy]propyl}dimethylazaniumyl)methylidyne

C12H14NO5 (252.0872)


4-Hydroxyvalerylcarnitine is an acylcarnitine. More specifically, it is an 4-hydroxypentanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-Hydroxyvalerylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine 4-Hydroxyvalerylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. In particular 4-Hydroxyvalerylcarnitine is elevated in the blood or plasma of individuals with 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency (PMID: 28583327) and holocarboxylase synthetase deficiency (PMID: 27114915). It is also decreased in the blood or plasma of individuals with psoriasis (PMID: 33391503). Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

2-Benzoyloxycinnamaldehyde

2-(3-Oxoprop-1-en-1-yl)phenyl benzoic acid

C16H12O3 (252.0786)


   

2-(Trifluoromethyl)benzhydrol

phenyl[2-(trifluoromethyl)phenyl]methanol

C14H11F3O (252.0762)


   

3'-Deoxyinosine

9-[3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-1H-purin-6-one

C10H12N4O4 (252.0859)


   

N-[1-(Hydroxymethyl)-2-(4-nitrophenyl)-2-oxoethyl]acetamide

N-[1-(Hydroxymethyl)-2-(4-nitrophenyl)-2-oxoethyl]acetamide

C11H12N2O5 (252.0746)


   

5-Ethynyl-2'-deoxyuridine

5-ethynyl-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione

C11H12N2O5 (252.0746)


   

Cndac

2-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-4-hydroxy-5-(hydroxymethyl)oxolane-3-carbonitrile

C10H12N4O4 (252.0859)


   

Glucose propionate

2,3,4,5-Tetrahydroxy-6-(hydroxymethyl)oxan-2-yl propanoic acid

C9H16O8 (252.0845)


   

S-Methyl-KE-298

4-(4-Methylphenyl)-2-[(methylsulphanyl)methyl]-4-oxobutanoic acid

C13H16O3S (252.082)


   

[(2R,3S,4R,5R)-3,4,5,6-Tetrahydroxy-1-oxohexan-2-yl] 2-hydroxypropanoate

[(2R,3S,4R,5R)-3,4,5,6-Tetrahydroxy-1-oxohexan-2-yl] 2-hydroxypropanoic acid

C9H16O8 (252.0845)


   

Thymine dimer

4a,4b-dimethyl-dodecahydro-1,3,6,8-tetraazabiphenylene-2,4,5,7-tetrone

C10H12N4O4 (252.0859)


   

2-Methoxyflavone

2-Methoxyflavone

C16H12O3 (252.0786)


   

Dehydroeffusal

Dehydroeffusal

C16H12O3 (252.0786)


   

1-Methoxy-2-methylanthraquinone

1-Methoxy-2-methylanthraquinone

C16H12O3 (252.0786)


   

6-Methoxyflavone

6-Methoxyflavone

C16H12O3 (252.0786)


   

7-Methoxyflavone

7-Methoxyflavone

C16H12O3 (252.0786)


7-Methoxyflavone is a compound isolated from Zornia brasiliensis. 7-Methoxyflavone has peripheral antinociceptive activity. 7-Methoxyflavone inhibits paw-licking time in the neurogenic phase of the formalin pain response (65.6\%) and did not decrease the nociceptive response in the inflammatory phase[1].

   

7-Hydroxy-2-methylisoflavone

7-hydroxy-2-methyl-3-phenylchromen-4-one

C16H12O3 (252.0786)


   

4-Methoxyflavone

4-Methoxyflavone

C16H12O3 (252.0786)


   

6-Methylflavonol

6-Methylflavonol

C16H12O3 (252.0786)


relative retention time with respect to 9-anthracene Carboxylic Acid is 1.301 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.299

   

7-Hydroxy-3-methylflavone

4H-1-Benzopyran-4-one,7-hydroxy-3-methyl-2-phenyl-

C16H12O3 (252.0786)


relative retention time with respect to 9-anthracene Carboxylic Acid is 1.155 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.156

   

2-benzylidene-6-methoxy-1-benzofuran-3-one

2-benzylidene-6-methoxy-1-benzofuran-3-one

C16H12O3 (252.0786)


   

5-Methoxyflavone

5-Methoxyflavone

C16H12O3 (252.0786)


   

4-O-((1S)-1-carboxyethyl)-D-mannose|4-O-(1-Carboxyethyl)mannose|4-O-(1-carboxyethyl)-D-mannose|4-O-(1-carboxyethyl)mannose|4-O-<1-carboxyethyl>mannose

4-O-((1S)-1-carboxyethyl)-D-mannose|4-O-(1-Carboxyethyl)mannose|4-O-(1-carboxyethyl)-D-mannose|4-O-(1-carboxyethyl)mannose|4-O-<1-carboxyethyl>mannose

C9H16O8 (252.0845)


   

9-(Hydroxymethyl)-10-vinyl-3H-naphtho[2,1-b]pyran-3-one

9-(Hydroxymethyl)-10-vinyl-3H-naphtho[2,1-b]pyran-3-one

C16H12O3 (252.0786)


   

2-Methoxy-3-methylanthracene-9,10-dione

2-Methoxy-3-methylanthracene-9,10-dione

C16H12O3 (252.0786)


   

Nordracorhodin

Nordracorhodin

C16H12O3 (252.0786)


   

O=Cc1c2c3c(c(C)c(O)cc3)ccc2cc(O)c1

O=Cc1c2c3c(c(C)c(O)cc3)ccc2cc(O)c1

C16H12O3 (252.0786)


   

1-methoxy-2-methylanthracene-9,10-dione

1-methoxy-2-methylanthracene-9,10-dione

C16H12O3 (252.0786)


   

Danshenxinkun C

Danshenxinkun C

C16H12O3 (252.0786)


   

8-Hydroxy-9-methyl-10-vinyl-3H-naphtho[2,1-b]pyran-3-one

8-Hydroxy-9-methyl-10-vinyl-3H-naphtho[2,1-b]pyran-3-one

C16H12O3 (252.0786)


   

7-Methyl-8-hydroxy-10-vinyl-3H-naphtho[2,1-b]pyran-3-one

7-Methyl-8-hydroxy-10-vinyl-3H-naphtho[2,1-b]pyran-3-one

C16H12O3 (252.0786)


   

1-hydroxy-2,7-dimethylanthraquinone

1-hydroxy-2,7-dimethylanthraquinone

C16H12O3 (252.0786)


   

3-((Xi)-Benzyliden)-6-methoxy-3H-benzofuran-2-on|3-Benzyliden-6-methoxy-cumaran-2-on|3-Benzylidene-6-methoxy-2(3H)-benzofuranone|3-benzylidene-6-methoxy-3H-benzofuran-2-one|6-methoxy-isoaurone|6-methoxyisoaurone

3-((Xi)-Benzyliden)-6-methoxy-3H-benzofuran-2-on|3-Benzyliden-6-methoxy-cumaran-2-on|3-Benzylidene-6-methoxy-2(3H)-benzofuranone|3-benzylidene-6-methoxy-3H-benzofuran-2-one|6-methoxy-isoaurone|6-methoxyisoaurone

C16H12O3 (252.0786)


   
   

9,10-Anthracenedione, 1-hydroxydimethyl-

9,10-Anthracenedione, 1-hydroxydimethyl-

C16H12O3 (252.0786)


   

1-hydroxy-3-ethyl-9,10-anthraquinone|3-Aethyl-1-hydroxy-anthrachinon|3-ethyl-1-hydroxy-anthraquinone|cordifoliol

1-hydroxy-3-ethyl-9,10-anthraquinone|3-Aethyl-1-hydroxy-anthrachinon|3-ethyl-1-hydroxy-anthraquinone|cordifoliol

C16H12O3 (252.0786)


   

2-benzoyloxycinnamaldehyde

2-benzoyloxycinnamaldehyde

C16H12O3 (252.0786)


   

CHEMBL1215503

CHEMBL1215503

C16H12O3 (252.0786)


   

2-Methyl-4-methoxyanthrachinon

2-Methyl-4-methoxyanthrachinon

C16H12O3 (252.0786)


   

2-(4-Hydroxyphenyl)-3-methylbenzofuran-5-carbaldehyde

2-(4-Hydroxyphenyl)-3-methylbenzofuran-5-carbaldehyde

C16H12O3 (252.0786)


   

A1-00200

InChI=1/C16H12O3/c1-18-12-7-8-13-14(17)10-15(19-16(13)9-12)11-5-3-2-4-6-11/h2-10H,1H

C16H12O3 (252.0786)


7-Methoxyflavone is a member of flavonoids and an ether. 7-Methoxyflavone is a natural product found in Ziziphus mauritiana, Conchocarpus heterophyllus, and other organisms with data available. 7-Methoxyflavone is a compound isolated from Zornia brasiliensis. 7-Methoxyflavone has peripheral antinociceptive activity. 7-Methoxyflavone inhibits paw-licking time in the neurogenic phase of the formalin pain response (65.6\%) and did not decrease the nociceptive response in the inflammatory phase[1].

   

Oprea1_109952

InChI=1/C16H12O3/c1-18-16-14(17)12-9-5-6-10-13(12)19-15(16)11-7-3-2-4-8-11/h2-10H,1H

C16H12O3 (252.0786)


3-Methoxyflavone is a flavonoid compound isolated from Artemisia incanescens with antiviral activity[1][2].

   

Nebularine

Nebularine

C10H12N4O4 (252.0859)


A purine ribonucleoside that is 9H-purine attached to a beta-D-ribofuranosyl residue at position 9 via a glycosidic (N-glycosyl) linkage. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000970 - Antineoplastic Agents relative retention time with respect to 9-anthracene Carboxylic Acid is 0.257 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.250

   

3-(4-methoxy-phenyl)-isochromen-1-one

NCGC00160252-01!3-(4-methoxy-phenyl)-isochromen-1-one

C16H12O3 (252.0786)


   

2-(2-methoxyphenyl)chromen-4-one

NCGC00168873-02!2-(2-methoxyphenyl)chromen-4-one

C16H12O3 (252.0786)


   

2-(4-methoxyphenyl)chromen-4-one

NCGC00095556-05!2-(4-methoxyphenyl)chromen-4-one

C16H12O3 (252.0786)


   

5-methoxy-2-phenylchromen-4-one

NCGC00142613-04!5-methoxy-2-phenylchromen-4-one

C16H12O3 (252.0786)


   

6-methoxy-2-phenylchromen-4-one

NCGC00177162-03!6-methoxy-2-phenylchromen-4-one

C16H12O3 (252.0786)


   

Deoxyinosine

2-Deoxyinosine

C10H12N4O4 (252.0859)


2’-deoxyadenosine inhibits the growth of human colon-carcinoma cell lines and is found to be associated with purine nucleoside phosphorylase (PNP) deficiency. 2’-deoxyadenosine inhibits the growth of human colon-carcinoma cell lines and is found to be associated with purine nucleoside phosphorylase (PNP) deficiency.

   

(2Z)-2-benzylidene-6-methoxy-1-benzofuran-3(2H)-one

(2Z)-2-benzylidene-6-methoxy-1-benzofuran-3(2H)-one

C16H12O3 (252.0786)


   

2-(4-methoxyphenyl)chromen-4-one [IIN-based on: CCMSLIB00000847204]

NCGC00095556-05!2-(4-methoxyphenyl)chromen-4-one [IIN-based on: CCMSLIB00000847204]

C16H12O3 (252.0786)


   

5-methoxy-2-phenylchromen-4-one [IIN-based on: CCMSLIB00000847375]

NCGC00142613-04!5-methoxy-2-phenylchromen-4-one [IIN-based on: CCMSLIB00000847375]

C16H12O3 (252.0786)


   

5-methoxy-2-phenylchromen-4-one [IIN-based: Match]

NCGC00142613-04!5-methoxy-2-phenylchromen-4-one [IIN-based: Match]

C16H12O3 (252.0786)


   

2-(4-methoxyphenyl)chromen-4-one [IIN-based: Match]

NCGC00095556-05!2-(4-methoxyphenyl)chromen-4-one [IIN-based: Match]

C16H12O3 (252.0786)


   

2-carboxylic acid derivative of Oxamniquine

2-carboxylic acid derivative of Oxamniquine

C11H12N2O5 (252.0746)


   

Anisindione

Anisindione

C16H12O3 (252.0786)


C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent

   

gamma-L-Glutaminyl-3,4-benzoquinone

2-amino-4-[(3,4-dioxocyclohexa-1,5-dien-1-yl)carbamoyl]butanoic acid

C11H12N2O5 (252.0746)


   

7-HYDROXY-3-METHYL-4-PHENYLCOUMARIN

7-HYDROXY-3-METHYL-4-PHENYLCOUMARIN

C16H12O3 (252.0786)


   

2-Butanone,2-(2,4-dinitrophenyl)hydrazone

2-Butanone,2-(2,4-dinitrophenyl)hydrazone

C10H12N4O4 (252.0859)


   

2-(4-hydroxyphenyl)-3-methylchromen-4-one

2-(4-hydroxyphenyl)-3-methylchromen-4-one

C16H12O3 (252.0786)


   

3-benzyloxybenzotrifluoride

3-benzyloxybenzotrifluoride

C14H11F3O (252.0762)


   

(4-FLUOROBENZYL)(PYRIDIN-4-YLMETHYL)AMINE

(4-FLUOROBENZYL)(PYRIDIN-4-YLMETHYL)AMINE

C13H14ClFN2 (252.0829)


   

2-Thiazolamine,4,5-diphenyl-

2-Thiazolamine,4,5-diphenyl-

C15H12N2S (252.0721)


   

7-Hydroxy-8-methyl-4-phenyl-2H-chromen-2-one

7-Hydroxy-8-methyl-4-phenyl-2H-chromen-2-one

C16H12O3 (252.0786)


   

(4-Trifluoromethylbiphenyl-4-yl)methanol

(4-Trifluoromethylbiphenyl-4-yl)methanol

C14H11F3O (252.0762)


   

1-oxo-2,3-dihydro-1h-inden-4-yl benzoate

1-oxo-2,3-dihydro-1h-inden-4-yl benzoate

C16H12O3 (252.0786)


   

5-(4-ETHYLTHIOPHENYL)-5-OXOVALERIC ACID

5-(4-ETHYLTHIOPHENYL)-5-OXOVALERIC ACID

C13H16O3S (252.082)


   

4-biphenyl-4-yl-thiazol-2-ylamine

4-biphenyl-4-yl-thiazol-2-ylamine

C15H12N2S (252.0721)


   

ethyl 4-acetamido-3-nitrobenzoate

ethyl 4-acetamido-3-nitrobenzoate

C11H12N2O5 (252.0746)


   

3-(1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL)PROPANOIC ACID

3-(1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL)PROPANOIC ACID

C10H12N4O4 (252.0859)


   

1,1,1,2,2,3,3-heptafluoronon-4-ene

1,1,1,2,2,3,3-heptafluoronon-4-ene

C9H11F7 (252.0749)


   

Glycine,N-(4-nitrobenzoyl)-, ethyl ester

Glycine,N-(4-nitrobenzoyl)-, ethyl ester

C11H12N2O5 (252.0746)


   

1-[(2-fluorophenyl)methyl]pyrazolo[3,4-b]pyridine-3-carbonitrile

1-[(2-fluorophenyl)methyl]pyrazolo[3,4-b]pyridine-3-carbonitrile

C14H9FN4 (252.0811)


   

2,5-diphenylthiazol-4-amine

2,5-diphenylthiazol-4-amine

C15H12N2S (252.0721)


   

4-AMINO-5-(3,5-DIMETHOXYPHENYL)-4H-1,2,4-TRIAZOLE-3-THIOL

4-AMINO-5-(3,5-DIMETHOXYPHENYL)-4H-1,2,4-TRIAZOLE-3-THIOL

C10H12N4O2S (252.0681)


   

DIMETHYL(N,N,N,N-TETRAMETHYLETHYLENEDIAMINE)PALLADIUM(II)

DIMETHYL(N,N,N,N-TETRAMETHYLETHYLENEDIAMINE)PALLADIUM(II)

C8H22N2Pd (252.0818)


   

Benzenemethanol, a-phenyl-a-(trifluoromethyl)-

Benzenemethanol, a-phenyl-a-(trifluoromethyl)-

C14H11F3O (252.0762)


   

4-Hydroxy-6-methylflavone

4-Hydroxy-6-methylflavone

C16H12O3 (252.0786)


   

3-(2-PHENYL-THIAZOL-4-YL)-PHENYLAMINE

3-(2-PHENYL-THIAZOL-4-YL)-PHENYLAMINE

C15H12N2S (252.0721)


   

2H-1-Benzopyran-3-carboxylic acid, 2-phenyl

2H-1-Benzopyran-3-carboxylic acid, 2-phenyl

C16H12O3 (252.0786)


   

7-(4-Fluoro-phenyl)-4,7-dioxo-heptanoic acid

7-(4-Fluoro-phenyl)-4,7-dioxo-heptanoic acid

C13H13FO4 (252.0798)


   

2,7-DIMETHYL-9-FLUORENONE-4-CARBOXYLIC ACID

2,7-DIMETHYL-9-FLUORENONE-4-CARBOXYLIC ACID

C16H12O3 (252.0786)


   

3-Trifluoromethylbenzhydrol

3-Trifluoromethylbenzhydrol

C14H11F3O (252.0762)


   

4-Benzoylphenyl acrylate

4-Benzoylphenyl acrylate

C16H12O3 (252.0786)


   

5-morpholino-2-nitrobenzenecarboxylic acid

5-morpholino-2-nitrobenzenecarboxylic acid

C11H12N2O5 (252.0746)


   

5-METHYL-7-HYDROXYISOFLAVONE

5-METHYL-7-HYDROXYISOFLAVONE

C16H12O3 (252.0786)


   

2-MORPHOLINO-5-NITROBENZOIC ACID

2-MORPHOLINO-5-NITROBENZOIC ACID

C11H12N2O5 (252.0746)


   

5-Ethynyl-2-deoxyuridine

5-Ethynyl-2-deoxyuridine

C11H12N2O5 (252.0746)


   

(4-TRIFLUOROMETHYLBIPHENYL-3-YL)METHANOL

(4-TRIFLUOROMETHYLBIPHENYL-3-YL)METHANOL

C14H11F3O (252.0762)


   

4-(Diacetoxymethyl)phenylboronic acid

4-(Diacetoxymethyl)phenylboronic acid

C11H13BO6 (252.0805)


   

(-)-Benzotetramisole

(-)-Benzotetramisole

C15H12N2S (252.0721)


   

naproxen sodium

naproxen sodium

C14H13NaO3 (252.0762)


D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D018501 - Antirheumatic Agents > D006074 - Gout Suppressants C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors

   
   

2H-1-BENZOPYRAN-2-ONE, 4-HYDROXY-3-(PHENYLMETHYL)-

2H-1-BENZOPYRAN-2-ONE, 4-HYDROXY-3-(PHENYLMETHYL)-

C16H12O3 (252.0786)


   

1-(4-methoxy-2,5-dimethylbenzyl)hydrazine dihydrochloride

1-(4-methoxy-2,5-dimethylbenzyl)hydrazine dihydrochloride

C10H18Cl2N2O (252.0796)


   

bis(Trimethylsilyl) Vinylphosphonate

bis(Trimethylsilyl) Vinylphosphonate

C8H21O3PSi2 (252.0767)


   

4,5-diphenyl-2-imidazolethiol

4,5-diphenyl-2-imidazolethiol

C15H12N2S (252.0721)


   

2-acetamido-3-(4-nitrophenyl)propanoic acid

2-acetamido-3-(4-nitrophenyl)propanoic acid

C11H12N2O5 (252.0746)


   

(R)-2-Acetamido-3-(4-nitrophenyl)propanoic acid

(R)-2-Acetamido-3-(4-nitrophenyl)propanoic acid

C11H12N2O5 (252.0746)


   

7-hydroxy-4-methyl-3-phenylcoumarin 97

7-hydroxy-4-methyl-3-phenylcoumarin 97

C16H12O3 (252.0786)


   

4-AMINO-5-(3,4-DIMETHOXY-PHENYL)-4H-[1,2,4]TRIAZOLE-3-THIOL

4-AMINO-5-(3,4-DIMETHOXY-PHENYL)-4H-[1,2,4]TRIAZOLE-3-THIOL

C10H12N4O2S (252.0681)


   
   

7-Acetamido-8-nitro-3,4-Dihydro-2H-1,5-benzodioxepine

7-Acetamido-8-nitro-3,4-Dihydro-2H-1,5-benzodioxepine

C11H12N2O5 (252.0746)


   

9-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]-3H-purine-2,6-dione

9-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]-3H-purine-2,6-dione

C10H12N4O4 (252.0859)


   

7-Hydroxy-5-methylflavone

7-Hydroxy-5-methylflavone

C16H12O3 (252.0786)


   

dl-2,3-diphenyl-succinic acid anhydride

dl-2,3-diphenyl-succinic acid anhydride

C16H12O3 (252.0786)


   

(+)-Benzotetramisole

(+)-Benzotetramisole

C15H12N2S (252.0721)


   

4-MORPHOLINO-3-NITROBENZOIC ACID

4-MORPHOLINO-3-NITROBENZOIC ACID

C11H12N2O5 (252.0746)


   

Benzenemethanol, a-phenyl-4-(trifluoromethyl)-

Benzenemethanol, a-phenyl-4-(trifluoromethyl)-

C14H11F3O (252.0762)


   

Butanal, (2,4-dinitrophenyl)hydrazone

Butanal, (2,4-dinitrophenyl)hydrazone

C10H12N4O4 (252.0859)


   

(2-THIEN-2-YLPHENYL)METHANOL

(2-THIEN-2-YLPHENYL)METHANOL

C14H11F3O (252.0762)


   

N-(2,4-Difluorophenyl)-3,5-dimethyl-1,2-oxazole-4-carboxamide

N-(2,4-Difluorophenyl)-3,5-dimethyl-1,2-oxazole-4-carboxamide

C12H10F2N2O2 (252.071)


   

(5-BROMOBENZO[B]FURAN-2-YL)METHYLAMINE

(5-BROMOBENZO[B]FURAN-2-YL)METHYLAMINE

C11H13ClN4O (252.0778)


   

3-Hydroxy-2,8-dimethyl-1,4-phenanthrenedione

3-Hydroxy-2,8-dimethyl-1,4-phenanthrenedione

C16H12O3 (252.0786)


   

AKOS BBS-00006148

AKOS BBS-00006148

C16H12O3 (252.0786)


   

ingenol 3-benzoate

ingenol 3-benzoate

C16H12O3 (252.0786)


   

(E)-2-BenzoyloxycinnaMaldehyde

2-(3-oxoprop-1-en-1-yl)phenyl benzoate

C16H12O3 (252.0786)


   

1,1,1,2-TETRAFLUORO-2-(TRIFLUOROMETHYL)OCT-3-ENE

1,1,1,2-TETRAFLUORO-2-(TRIFLUOROMETHYL)OCT-3-ENE

C9H11F7 (252.0749)


   

AKOS BBS-00006149

AKOS BBS-00006149

C16H12O3 (252.0786)


   

2,4,6-Cycloheptatrien-1-one,2-hydroxy-3-(1-oxo-3-phenyl-2-propen-1-yl)-

2,4,6-Cycloheptatrien-1-one,2-hydroxy-3-(1-oxo-3-phenyl-2-propen-1-yl)-

C16H12O3 (252.0786)


   

Propanal, 2-methyl-,2-(2,4-dinitrophenyl)hydrazone

Propanal, 2-methyl-,2-(2,4-dinitrophenyl)hydrazone

C10H12N4O4 (252.0859)


   

4-Benzyloxybenzotrifluoride

4-Benzyloxybenzotrifluoride

C14H11F3O (252.0762)


   

N-(4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-2-yl)-2,2-dimethylpropionamide

N-(4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-2-yl)-2,2-dimethylpropionamide

C11H13ClN4O (252.0778)


   

4-Morpholin-4-yl-2-nitrobenzoic acid

4-Morpholin-4-yl-2-nitrobenzoic acid

C11H12N2O5 (252.0746)


   

Cndac

Cndac

C10H12N4O4 (252.0859)


A pyrimidine 2-deoxyribonucleoside that is 2-deoxycytidine having a cyano group in the 2-position. It is the active metabolite of the anti-cancer drug, sapacitabine which is currently in clinical development for the treatment of hematologic malignancies and solid tumors. C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite

   
   

S-Methyl-KE-298

S-Methyl-KE-298

C13H16O3S (252.082)


   

8-Methoxyflavone

8-Methoxyflavone

C16H12O3 (252.0786)


   

(5-Methoxy-3-benzofuranyl)-phenylmethanone

(5-Methoxy-3-benzofuranyl)-phenylmethanone

C16H12O3 (252.0786)


   

5-(3,4,5-Trimethoxyphenyl)-1,3,4-oxadiazol-2-ol

5-(3,4,5-Trimethoxyphenyl)-1,3,4-oxadiazol-2-ol

C11H12N2O5 (252.0746)


   

2-(p-Hydroxyphenyl)-3-benzofuranyl methyl ketone

2-(p-Hydroxyphenyl)-3-benzofuranyl methyl ketone

C16H12O3 (252.0786)


   

3-(4-Methoxyphenyl)-1h-isochromen-1-one

3-(4-Methoxyphenyl)-1h-isochromen-1-one

C16H12O3 (252.0786)


   

Trimethylsilyl acetylsalicylate

Trimethylsilyl acetylsalicylate

C12H16O4Si (252.0818)


   

4H-Naphtho[1,2-b]pyran-4-one, 3-acetyl-2-methyl-

4H-Naphtho[1,2-b]pyran-4-one, 3-acetyl-2-methyl-

C16H12O3 (252.0786)


   

4-(Acetylamino)-3-[(hydroxyacetyl)amino]benzoic acid

4-(Acetylamino)-3-[(hydroxyacetyl)amino]benzoic acid

C11H12N2O5 (252.0746)


   

(5r)-2-[(2-Fluorophenyl)amino]-5-(1-Methylethyl)-1,3-Thiazol-4(5h)-One

(5r)-2-[(2-Fluorophenyl)amino]-5-(1-Methylethyl)-1,3-Thiazol-4(5h)-One

C12H13FN2OS (252.0733)


   

ACon1_000249

5-18-02-00257 (Beilstein Handbook Reference)

C16H12O3 (252.0786)


   

AIDS-126400

7-Hydroxy-2-methyl-3-phenyl-4H-chromen-4-one

C16H12O3 (252.0786)


   
   

(2S,3S,6R)-6-(4-amino-2-oxopyrimidin-1-yl)-3-azaniumyl-3,6-dihydro-2H-pyran-2-carboxylate

(2S,3S,6R)-6-(4-amino-2-oxopyrimidin-1-yl)-3-azaniumyl-3,6-dihydro-2H-pyran-2-carboxylate

C10H12N4O4 (252.0859)


   

7-Imino-5-methylphenazine-1-carboxylate

7-Imino-5-methylphenazine-1-carboxylate

C14H10N3O2- (252.0773)


   

(R)-N-formyl-beta-hydroxy-L-kynurenine

(R)-N-formyl-beta-hydroxy-L-kynurenine

C11H12N2O5 (252.0746)


   

4aalpha,8aalpha-Dimethyl-4a,4balpha,8a,8balpha-tetrahydrocyclobuta[1,2-d:3,4-d]dipyrimidine-2,4,6,8(1H,3H,5H,7H)-tetraone

4aalpha,8aalpha-Dimethyl-4a,4balpha,8a,8balpha-tetrahydrocyclobuta[1,2-d:3,4-d]dipyrimidine-2,4,6,8(1H,3H,5H,7H)-tetraone

C10H12N4O4 (252.0859)


   

(2S,3R)-2-amino-4-(2-formamidophenyl)-3-hydroxy-4-oxobutanoic acid

(2S,3R)-2-amino-4-(2-formamidophenyl)-3-hydroxy-4-oxobutanoic acid

C11H12N2O5 (252.0746)


   

9-[3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one

9-[3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one

C10H12N4O4 (252.0859)


   

[2,3,4,5-Tetrahydroxy-6-(hydroxymethyl)oxan-2-yl] propanoate

[2,3,4,5-Tetrahydroxy-6-(hydroxymethyl)oxan-2-yl] propanoate

C9H16O8 (252.0845)


   

[(2R,3S,4R,5R)-3,4,5,6-Tetrahydroxy-1-oxohexan-2-yl] 2-hydroxypropanoate

[(2R,3S,4R,5R)-3,4,5,6-Tetrahydroxy-1-oxohexan-2-yl] 2-hydroxypropanoate

C9H16O8 (252.0845)


   

5,7-Difluoro-6-methoxy-2,3,4,9-tetrahydropyrido[3,4-b]indol-1-one

5,7-Difluoro-6-methoxy-2,3,4,9-tetrahydropyrido[3,4-b]indol-1-one

C12H10F2N2O2 (252.071)


   

4-(2-chloro-6-fluorobenzyl)-1,3,5-trimethyl-1H-pyrazole

4-(2-chloro-6-fluorobenzyl)-1,3,5-trimethyl-1H-pyrazole

C13H14ClFN2 (252.0829)


   

(2R)-2-acetamido-3-(phenylmethylthio)propanoate

(2R)-2-acetamido-3-(phenylmethylthio)propanoate

C12H14NO3S- (252.0694)


   

Methyl trimethylsilyl phthalate

Methyl trimethylsilyl phthalate

C12H16O4Si (252.0818)


   

Benzoic acid, 4-acetyloxy-, trimethylsilyl ester

Benzoic acid, 4-acetyloxy-, trimethylsilyl ester

C12H16O4Si (252.0818)


   

Methyl trimethylsilyl isophthalate

Methyl trimethylsilyl isophthalate

C12H16O4Si (252.0818)


   

1,4-Benzenedicarboxylic acid, methyl trimethylsilyl ester

1,4-Benzenedicarboxylic acid, methyl trimethylsilyl ester

C12H16O4Si (252.0818)


   

4-Methoxybenzoylformic acid, TMS

4-Methoxybenzoylformic acid, TMS

C12H16O4Si (252.0818)


   

3,4-Methylenedioxyphenylacetic acid, trimethylsilyl ester

3,4-Methylenedioxyphenylacetic acid, trimethylsilyl ester

C12H16O4Si (252.0818)


   

2-Deoxyinosine

2-Deoxyinosine

C10H12N4O4 (252.0859)


A purine 2-deoxyribonucleoside that is inosine in which the hydroxy group at position 2 is replaced by a hydrogen. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS 2’-deoxyadenosine inhibits the growth of human colon-carcinoma cell lines and is found to be associated with purine nucleoside phosphorylase (PNP) deficiency. 2’-deoxyadenosine inhibits the growth of human colon-carcinoma cell lines and is found to be associated with purine nucleoside phosphorylase (PNP) deficiency.

   

5-hydroxy-N-formyl-L-kynurenine

5-hydroxy-N-formyl-L-kynurenine

C11H12N2O5 (252.0746)


   

7-hydroxy-2-methyl-3-phenylchromen-4-one

7-Hydroxy-2-methyl-3-phenyl-4H-chromen-4-one

C16H12O3 (252.0786)


   

5-Hydroxy-N-formylkynurenine

5-Hydroxy-N-formylkynurenine

C11H12N2O5 (252.0746)


A non-proteinogenic alpha-amino acid that is 5-hydroxykynurenine bearing an N-formyl substituent.

   

4a,4b-dimethylhexahydro-1,3,6,8-tetraazabiphenylene-2,4,5,7-tetrone

4a,4b-dimethylhexahydro-1,3,6,8-tetraazabiphenylene-2,4,5,7-tetrone

C10H12N4O4 (252.0859)


A member of the class of cyclobutadipyrimidines that is hexahydro-1,3,6,8-tetraazabiphenylene-2,4,5,7-tetrone carrying two additional methyl substituents at positions 4a and 4b.

   

N5-(3,4-Dioxo-1,5-cyclohexadien-1-yl)-L-glutamine

N5-(3,4-Dioxo-1,5-cyclohexadien-1-yl)-L-glutamine

C11H12N2O5 (252.0746)


   

Hypoxanthine, 9-(2-deoxy-beta-D-erythro-pentofuranosyl)-

Hypoxanthine, 9-(2-deoxy-beta-D-erythro-pentofuranosyl)-

C10H12N4O4 (252.0859)


   

2-(4-Hydroxyphenyl)-3-benzofuranyl methyl ketone

1-[2-(4-Hydroxyphenyl)-1-benzofuran-3-yl]ethanone

C16H12O3 (252.0786)


   

N-acetyl-S-benzyl-L-cysteine(1-)

N-acetyl-S-benzyl-L-cysteine(1-)

C12H14NO3S (252.0694)


An S-substituted N-acetyl-L-cysteinate that is the conjugate base of N-acetyl-S-benzyl-L-cysteine resulting from the deprotonation of the carboxy group; major species at pH 7.3.

   

Hydroxy-N-formylkynurenine

Hydroxy-N-formylkynurenine

C11H12N2O5 (252.0746)


   
   

3-Hydroxy-6-methylflavone

3-Hydroxy-6-methylflavone

C16H12O3 (252.0786)


   

Methoxyisoflavone

Methoxyisoflavone

C16H12O3 (252.0786)


   

4'-O-Methylisoflavone

4'-O-Methylisoflavone

C16H12O3 (252.0786)


   

O-Methylisoflavone

O-Methylisoflavone

C16H12O3 (252.0786)


   

3'-Deoxyinosine

3'-Deoxyinosine

C10H12N4O4 (252.0859)


3'-Deoxyinosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

   

(2s)-2-[(3,4-dioxocyclohexa-1,5-dien-1-yl)amino]-4-(c-hydroxycarbonimidoyl)butanoic acid

(2s)-2-[(3,4-dioxocyclohexa-1,5-dien-1-yl)amino]-4-(c-hydroxycarbonimidoyl)butanoic acid

C11H12N2O5 (252.0746)


   

10-ethenyl-8-hydroxy-9-methylbenzo[f]chromen-3-one

10-ethenyl-8-hydroxy-9-methylbenzo[f]chromen-3-one

C16H12O3 (252.0786)


   

3-[3-(2h-1,3-benzodioxol-5-yl)phenyl]prop-2-enal

3-[3-(2h-1,3-benzodioxol-5-yl)phenyl]prop-2-enal

C16H12O3 (252.0786)


   

2-amino-4-{5-hydroxy-2-[(hydroxymethylidene)amino]phenyl}-4-oxobutanoic acid

2-amino-4-{5-hydroxy-2-[(hydroxymethylidene)amino]phenyl}-4-oxobutanoic acid

C11H12N2O5 (252.0746)


   

2-hydroxy-3-methylanthraquinone; me ether

NA

C16H12O3 (252.0786)


{"Ingredient_id": "HBIN005746","Ingredient_name": "2-hydroxy-3-methylanthraquinone; me ether","Alias": "NA","Ingredient_formula": "C16H12O3","Ingredient_Smile": "NA","Ingredient_weight": "252.26","OB_score": "NA","CAS_id": "17241-42-8","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8619","PubChem_id": "NA","DrugBank_id": "NA"}

   

10-ethenyl-8-hydroxy-7-methylbenzo[f]chromen-3-one

10-ethenyl-8-hydroxy-7-methylbenzo[f]chromen-3-one

C16H12O3 (252.0786)


   

(2s,3r,4s,5s)-2-(hydroxymethyl)-5-(purin-9-yl)oxolane-3,4-diol

(2s,3r,4s,5s)-2-(hydroxymethyl)-5-(purin-9-yl)oxolane-3,4-diol

C10H12N4O4 (252.0859)


   

(2r)-2-{[(2r,3s,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}propanoic acid

(2r)-2-{[(2r,3s,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}propanoic acid

C9H16O8 (252.0845)


   

2-{[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}propanoic acid

2-{[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}propanoic acid

C9H16O8 (252.0845)


   

inosine, 2'-deoxy-

inosine, 2'-deoxy-

C10H12N4O4 (252.0859)


   

2,7-dihydroxy-8-methylphenanthrene-4-carbaldehyde

2,7-dihydroxy-8-methylphenanthrene-4-carbaldehyde

C16H12O3 (252.0786)


   

2-[(3,4-dioxocyclohexa-1,5-dien-1-yl)amino]-4-(c-hydroxycarbonimidoyl)butanoic acid

2-[(3,4-dioxocyclohexa-1,5-dien-1-yl)amino]-4-(c-hydroxycarbonimidoyl)butanoic acid

C11H12N2O5 (252.0746)


   

2'-deoxy-inosine

2'-deoxy-inosine

C10H12N4O4 (252.0859)


   

1-methoxy-3-methylanthracene-9,10-dione

1-methoxy-3-methylanthracene-9,10-dione

C16H12O3 (252.0786)


   

2-[(1e)-3-oxoprop-1-en-1-yl]phenyl benzoate

2-[(1e)-3-oxoprop-1-en-1-yl]phenyl benzoate

C16H12O3 (252.0786)


   

(5s)-3-hydroxy-4,5-diphenyl-5h-furan-2-one

(5s)-3-hydroxy-4,5-diphenyl-5h-furan-2-one

C16H12O3 (252.0786)


   

5-methoxy-2-phenylchromen-7-one

5-methoxy-2-phenylchromen-7-one

C16H12O3 (252.0786)


   

2-(3-methoxyphenyl)chromen-4-one

2-(3-methoxyphenyl)chromen-4-one

C16H12O3 (252.0786)


   

10-ethenyl-9-(hydroxymethyl)benzo[f]chromen-3-one

10-ethenyl-9-(hydroxymethyl)benzo[f]chromen-3-one

C16H12O3 (252.0786)


   

2-methoxy-7-methylanthracene-9,10-dione

2-methoxy-7-methylanthracene-9,10-dione

C16H12O3 (252.0786)


   

1-hydroxy-2,3-dimethylanthracene-9,10-dione

1-hydroxy-2,3-dimethylanthracene-9,10-dione

C16H12O3 (252.0786)


   

4'-methoxyisoflavone

4'-methoxyisoflavone

C16H12O3 (252.0786)